146 related articles for article (PubMed ID: 12540521)
1. Inhibition of kinin breakdown prolongs retention and action of bradykinin in a myocardial B2 receptor compartment.
Dendorfer A; Folkers V; Klinger M; Wolfrum S; Dominiak P
Br J Pharmacol; 2003 Jan; 138(2):310-6. PubMed ID: 12540521
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of the vascular response to kinins by inhibition of myocardial kininases.
Dendorfer A; Wolfrum S; Schäfer U; Stewart JM; Inamura N; Dominiak P
Hypertension; 2000 Jan; 35(1 Pt 1):32-7. PubMed ID: 10642271
[TBL] [Abstract][Full Text] [Related]
3. Expression of metallopeptidases and kinin receptors in swine oropharyngeal tissues: effects of angiotensin I-converting enzyme inhibition and inflammation.
Moreau ME; Dubreuil P; Molinaro G; Chagnon M; Müller-Esterl W; Lepage Y; Marceau F; Adam A
J Pharmacol Exp Ther; 2005 Dec; 315(3):1065-74. PubMed ID: 16166273
[TBL] [Abstract][Full Text] [Related]
4. Kinins, receptors, kininases and inhibitors--where did they lead us?
Erdös EG; Marcic BM
Biol Chem; 2001 Jan; 382(1):43-7. PubMed ID: 11258670
[TBL] [Abstract][Full Text] [Related]
5. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat.
Sulpizio AC; Pullen MA; Edwards RM; Brooks DP
J Pharmacol Exp Ther; 2004 Jun; 309(3):1141-7. PubMed ID: 14769834
[TBL] [Abstract][Full Text] [Related]
6. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
[TBL] [Abstract][Full Text] [Related]
7. Vascular catabolism of bradykinin in the isolated perfused rat kidney.
Bagaté K; Develioglu L; Grima M; De Jong W; Simmons WH; Imbs JL; Barthelmebs M
Eur J Pharmacol; 2000 Nov; 407(3):317-25. PubMed ID: 11068029
[TBL] [Abstract][Full Text] [Related]
8. Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors.
Scharfstein J; Schmitz V; Morandi V; Capella MM; Lima AP; Morrot A; Juliano L; Müller-Esterl W
J Exp Med; 2000 Nov; 192(9):1289-300. PubMed ID: 11067878
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of angiotensin-converting enzyme reduces rat liver reperfusion injury via bradykinin-2-receptor.
Freise H; Palmes D; Spiegel HU
J Surg Res; 2006 Aug; 134(2):231-7. PubMed ID: 16513137
[TBL] [Abstract][Full Text] [Related]
10. [ACE inhibitors--activators of kinin receptors].
Kugaevskaia EV; Eliseeva IuE
Biomed Khim; 2011; 57(3):282-99. PubMed ID: 21863742
[TBL] [Abstract][Full Text] [Related]
11. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
[TBL] [Abstract][Full Text] [Related]
12. Enzymatic digestion of bradykinin by rat Sertoli cell cultures.
Monsees TK; Miska W; Schill WB
J Androl; 1996; 17(4):375-81. PubMed ID: 8889700
[TBL] [Abstract][Full Text] [Related]
13. Bradykinin in ischemia-reperfusion injury of the rat lung.
Nowak K; Weih S; Post S; Gebhard MM; Hohenberger P
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):513-22. PubMed ID: 18204165
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
15. Cardiac kinin level in experimental diabetes mellitus: role of kininases.
Koch M; Wendorf M; Dendorfer A; Wolfrum S; Schulze K; Spillmann F; Schultheiss HP; Tschöpe C
Am J Physiol Heart Circ Physiol; 2003 Jul; 285(1):H418-23. PubMed ID: 12637359
[TBL] [Abstract][Full Text] [Related]
16. Zaltoprofen, a non-steroidal anti-inflammatory drug, inhibits bradykinin-induced pain responses without blocking bradykinin receptors.
Hirate K; Uchida A; Ogawa Y; Arai T; Yoda K
Neurosci Res; 2006 Apr; 54(4):288-94. PubMed ID: 16473424
[TBL] [Abstract][Full Text] [Related]
17. TNF-alpha and IL-1beta mediate inflammatory hypernociception in mice triggered by B1 but not B2 kinin receptor.
Cunha TM; Verri WA; Fukada SY; Guerrero AT; Santodomingo-Garzón T; Poole S; Parada CA; Ferreira SH; Cunha FQ
Eur J Pharmacol; 2007 Nov; 573(1-3):221-9. PubMed ID: 17669394
[TBL] [Abstract][Full Text] [Related]
18. Does insulin release kinins in rats?
Damas J; Garbacki N; Lefèbvre PJ
Eur J Pharmacol; 2005 Nov; 525(1-3):154-60. PubMed ID: 16297383
[TBL] [Abstract][Full Text] [Related]
19. Vascular B1 kinin receptors in patients with congestive heart failure.
Lang NN; Cruden NL; Tse GH; Bloomfield P; Ludlam CA; Fox KA; Newby DE
J Cardiovasc Pharmacol; 2008 Nov; 52(5):438-44. PubMed ID: 19033823
[TBL] [Abstract][Full Text] [Related]
20. MEN16132, a novel potent and selective nonpeptide kinin B2 receptor antagonist: in vivo activity on bradykinin-induced bronchoconstriction and nasal mucosa microvascular leakage in anesthetized guinea pigs.
Valenti C; Cialdai C; Giuliani S; Lecci A; Tramontana M; Meini S; Quartara L; Maggi CA
J Pharmacol Exp Ther; 2005 Nov; 315(2):616-23. PubMed ID: 16027229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
